1 / 61

SPEAKER’S PROFILE Drs. Jahja Santoso, Pharmacist

SPEAKER’S PROFILE Drs. Jahja Santoso, Pharmacist. Educational background : Bandung Institute of Technology , Pharmacy college. Current Functions :

nissim-hewitt
Download Presentation

SPEAKER’S PROFILE Drs. Jahja Santoso, Pharmacist

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SPEAKER’S PROFILEDrs. Jahja Santoso, Pharmacist • Educational background : Bandung Institute of Technology, Pharmacy college. • Current Functions : • Owner and President Director of PT Sanbe Farma, the largest pharmaceutical manufacturing company in Indonesia among more than 200 pharmaceutical companies. (website : www.sanbe-farma.com) • Owner and President Director of PT Caprifarmindo Laboratories (website : www.caprifarmindo.com) • Owner of Santosa Bandung International Hospital (website : www.santosa-hospital.com) • Owner and President Director of PT Bina San Prima, General Trading & Distributor (website : www.binasanprima.com) • Owner of the Holiday Inn International Hotel in Bandung / Ibis Hotel in Semarang • Member Board of Trustee, Padjadjaran University • Honorary Title Prince of Central Java Kingdom • Founder of Santoso Charity Foundation with 75 orphanage houses and 2,000 students with scholarship. • Honorary Consul of The Republic of Latvia, for West Java & Bali (Indonesia) • Owner of San Diamond Jewelry

  2. Invest in Presented by : Drs. Jahja Santoso, Pharmacist Honorary Consul of The Republic of Latvia For West Java & Bali June 07, 2011

  3. INDONESIA • Biggest archipelago country in the world • - Island : > 17,000 • - Lands : ± 2 million km2 • - Sea : ± 5,8 million km2 • - Coastal line : ± 81,000 km • Population : 240,000,000 people • Hundreds of ethnics • More than 750 languages & dialects • One of biggest democratic country 6,435 Km

  4. Snapshot of Indonesia’s Macro Condition Snapshot of Indonesia’s Macro Condition Note : Nominal per-capita GDP is expected to quadruple by 2020 as per Standard Chartered Source: Bank Indonesia, Investment Coordinating Board / BKPM

  5. INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES KEY STRENGTHS • Of the 240 million people in Indonesia, over 50% of the population is under 29 years old • Rapidly urbanizing population provides for labor force in centers of investment • Dynamic labor market participation with a growth of 2.3 million people per year Dynamic and youthful population

  6. INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES KEY STRENGTHS 2. Abundance of natural resources

  7. INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES KEY STRENGTHS 2. Abundance of natural resources

  8. INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES KEY STRENGTHS • The services sector has grown over 16 percentage points from 1998 to 2009. • Private consumption accounts for 70% of GDP and has increased by 5.3% in 2008 • Consumer confidence index rose by nearly 10% in November 2009 (year-on-year) • Over 50% of the population live in urban areas and adopt a modern lifestyle 3. Burgeoning Domestic Market

  9. INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES KEY STRENGTHS • Indonesia lies strategically in the intersection of the Pacific Ocean, along the Malacca Straits and the Indian ocean • Over half of all international shipping travel through Indonesian waters • The only country in South-east Asia that is a member of G-20 • An active and strong voice of developing countries in global discussions on issues around climate change, global economy architecture, etc 4. Strategic Location and Increasing Global Presence

  10. INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES KEY STRENGTHS • Government is committed to making education a priority: • Education spending accounts for 16% of total government expenditures • University graduates are trained in technical fields such as finance and economics (28%) or engineering and sciences (27.5%) • Labor cost is relatively low (USD 0.6 per hour), even as compared to investment magnets China (USD 2.11 per hour) and India (USD 1.03 per hour) 5. Increasingly skilled labor force

  11. INDONESIA’S UNIQUE STRENGTHS AND OPPORTUNITIES KEY STRENGTHS • Investment Law (2007) • - Equal Treatment for foreign & domestic investors • - No Minimum Capital Requirement • - Divestment not required • - Free to Repatriate Investment & Profit • - Legal Guarantee • - Dispute Settlement • - Investment Services • Establishment of a one-door integrated service and a nationalsingle window for investment, enhancing investment coordination and facilitation. • Listed as one of ten countries improving investor protections as per Doing Business Report 2010 by IFC (International Finance Corporation) 6. On-going reform in investment climate

  12. Stimulus Tax and Duties covered by government Income Tax Reduction for Individual & Geothermal Development Speeding Up Infrastructure Development Discount Price for Power & Energy Intensify discussion on facilities for foreign investments including integrated services and reviewing of fiscal facilities

  13. 2010 Foreign Direct Investment (FDI) Confidence Index

  14. Conclusion • Indonesia with its big population, abundant natural resources, on-going reform in investment climate is a promising country for investment. • Government has commitment to support investment in Indonesia with its Investment Law 2007. • Indonesia is ranked as the 20th FDI (Foreign Direct Investment) destination country in 2010.

  15. For further information, please contact : • Chairman : Gita I. Wirjawan • Deputy Chairman of Investment Promotion : • Ir.Darmawan Dj., MA • Website : www.bkpm.go.id • Office Address : • Jl. Jend. Gatot Subroto No. 44, Jakarta 12190 • P.O. Box 3186, Indonesia • Phone : +62 21 5292 1334 • Fax : +62 21 5264 211 • E-mail : info@bkpm.go.id * INDONESIA INVESTMENT COORDINATING BOARD

  16. INDONESIAN PHARMACEUTICAL OVERVIEW Presented by : Drs. Jahja Santoso, Pharmacist Honorary Consul of The Republic of Latvia For West Java & Bali June 07, 2011

  17. INDONESIAN CONDITION • Hospitals 1,200 • Total Doctors 40,000 • Specialist 10,000 • General Practitioner 24,000 • Dentist 6,000 • Ratio Doctor to Patient: Way below WHO standard • Primary Health Care 7,000 • Pharmacies 7,000

  18. HEALTH BUDGET IN INDONESIA FROM YEAR TO YEAR • IDR 5.8 trillion • IDR 13.5 trillion • IDR 15.1 trillion • IDR 16 trillion • IDR 19.3 trillion • 2010 IDR 26 trillion Source : from various sources Note : USD 1 = Rp 9,000

  19. Health Expenditure Comparison in ASEAN countries

  20. INDONESIAN PHARMACEUTICAL MARKET • Pharma Market size in 2010 : around USD 4 Billion • Market growth : 14.10 % per year • There are presently 200 local and 35 foreign pharmaceutical companies • Patent Law: effective as of 1 January 2000

  21. INDONESIAN PHARMACEUTICAL MARKET Pharma Market Characteristic : • Capital Intensive • High tech, Highly fragmented, Highly regulated • Multiproduct line • High imported content • Small percentage of people covered by insurance

  22. PHARMA MARKET TREND IN INDONESIA 2001-2007 Value in billion rupiah Source : Bisnis Indonesia 12 Feb 2008 Note : USD 1 = Rp 9,000

  23. BIG FIVE PHARMACEUTICAL COMPANIES IN INDONESIA Source : Suara Pembaruan daily newspaper, September 25, 2010

  24. Share of OTC & Prescription - Pharma Market Total Registered Product: 15,911 Items Source : IMS Health

  25. PRESCRIPTION PHARMACEUTICAL MARKET SHARE Source : IMS Health, Fiscal Year 2009 (Ethical)

  26. PRESCRIPTION PHARMACEUTICAL MARKET SHARE Source : IMS Health, Fiscal Year 2009 (Ethical)

  27. EXPORTED PHARMACEUTICAL PRODUCT FROM INDONESIA 2001-2005 AND JANUARY-JULY 2006 VALUE IN THOUSAND US$ Source : Central Bureau of Statistics

  28. IMPORTED PHARMACEUTICAL PRODUCTS TO INDONESIA FROM COUNTRY OF ORIGIN in 2001-2005 AND JANUARY-JULY 2006 VALUE IN THOUSAND US$ Source : Central Bureau of Statistics

  29. Pharmaceutical Business Condition The Indonesia Pharmaceutical market is still potential enough considering the population number, GDP and drug consumption. Industry needs to invest in order to comply with cGMP regulation Minister of Health Decree No. 1010/Menkes/PER/XI/2008: Registration of imported drug shall be performed by domestic pharmaceutical industry with written authorization from foreign pharmaceutical industry. Technology transfer shall be done within 5 years the latest in order that the product be produced locally. Regulation about National Social Security System / SJSN and Health Insurance for poor population.

  30. Opportunity to grow is still available for pharmaceutical industry in Indonesia : Indonesia as one country with the lowest medicine consumption per capita in ASEAN Indonesian vision to be high income country in 2030 (US$18,000 per capita) Indonesian people is projected to be 285 million in 2030 Source : Yayasan Indonesia Forum 2007; BisnisFarmasi 2007, WordPress.com OPPORTUNITY FOR PHARMACEUTICAL INDUSTRY 30

  31. For Further information, please contact : GP Farmasi (Indonesian Pharmaceutical Association) The only pharmaceutical association inIndonesia:covering Manufacturer,Distributor, Pharmacy & Drug Stores based on Ministry of Health Decree no 222/1969 Members: • Foreign 33 • National 172 (4 State Owned) • Wholesaler 2,463 • Pharmacy 7,671 • Drug store 5,513 (Licenced)

  32. Chairman of GP Farmasi : Mr. Anthony CH. Sunarjo, MBA. (e-mail address : anthony.sunarjo@gmail.com) • Executive Secretary : Buddy Nataatmadja (e-mail address : buddynataatmadja@gmail.com) Website : www.gpfarmasi.org Office address : Jl. Angkasa No. 20 A Jakarta – 10620 Indonesia E-mail : sekretariat@gpfarmasi.org Phone : +62 21 4203040 Fax : +62 21 4203047; +62 21 4203048

  33. REGULATORY FUNCTION ON PHARMACEUTICALS IN INDONESIA

  34. NATIONAL AGENCY OF DRUG AND FOOD CONTROL (NADFC) as National Regulatory Authority in Indonesia, consistent with : • Good Drug Regulatory Practices (GDRP); QA ; Standardization; Self-regulatory Code; Inspection and Audit • Good Management Practices (GMgP); Transparancies and fairness; SOPs; Cost- recovery; incentive/ disincentive

  35. REGULATORY SYSTEM for Pharmaceuticals in Indonesia • Consistency in regulation • Transparency of services ~ Multi National Companies Domestic Companies No discrimination on Standard and Requirement

  36. PHARMACEUTICALS (DRUGS AND BIOLOGICALS) SISPOM (National System on D&F Control) IMPORT IMPORT QUALITY, SAFETY, and EFFICACY of PHARMACEUTICALS EXPORT EXPORT SISPOM

  37. REGISTRATION DOSSIER • Registration dossier for all pharmaceutical products (drug and biological products) should be submitted in ACTD (ASEAN Common Technical Dossier) format in line with ASEAN harmonization.

  38. For further information, please contact : National Agency of Drug and Food Control (NADFC) Head of National Agency of Drug and Food Control : Dra. Kustantinah, Pharmacist, MAppSc. Website : www.pom.go.id Jl. Percetakan Negara No. 23 Jakarta – 10560 Indonesia Phone : 62 21 4244691 / 42883309 / 42883462 Fax : 62 21 4263333 E-mail address : informasi@pom.go.id

  39. PT BINA SAN PRIMA GENERAL TRADING & DISTRIBUTOR • PT Bina San Prima was established in 1994 • 38 branches and 17 sub distributors throughout Indonesia • Total 4,035 employees including 155 sales supervisor, 755 salesmen • Vehicle : 355 canvassing cars, 142 motor boxes COMPETITIVE ADVANTAGES • Strong financial back up • Same day delivery service • Strong field forces • Excellent coverage • Computer integrated information system • Nationwide distribution network • Professionally managed

  40. ACHIEVEMENT AWARDS

  41. ACHIEVEMENT AWARDS

  42. Contact Us : PT BINA SAN PRIMA Operation & Brand Director : Andi MS • E-mail address : andi@binasanprima.com • Phone : +62 22 4207725 ext. 502 – 503 • Fax : +62 22 4261031 • Jl. Purnawarman 47 Bandung 40116 West Java - Indonesia

  43. CONCLUSION • The Indonesian Pharmaceutical market is still potential enough considering the population number, GDP and drug consumption per capita • NADFC as the regulatory authority in Indonesia commits to treat the foreign and domestic pharmaceutical companies with same standard and requirement.

  44. FOOD & BEVERAGES, WOOD, PULP & PAPER BUSINESS OPPORTUNITY IN INDONESIA Presented by : Drs. Jahja Santoso, Pharmacist Honorary Consul of The Republic of Latvia For West Java & Bali June 07, 2011

  45. Indonesia Consumers’ Characteristics 30 millions live in big city with sufficient buying power 100 millions low buying power, 38 millions poor 60% live in Java island, 21% in Sumatera 58% live in rural area, 42% in city 87% Moslems (200 millions) : need Halal Foods 55% < 25 years old 480 ethnics in Indonesia Rice is a main staple food

  46. Characteristics of Food & Beverages Business in Indonesia • Total consumption of Food & Beverages & tobacco in 2009 : +/- Rp 1,700 trillion • Fresh & unprocessed foods : +/- Rp 1,000 trillion • Consumption of processed foods : +/- Rp 505 trillion • Consumption of cigarettes & processed tobacco: +/- Rp 120 trillion • Many malls & modern retails are built (Mini / Super / Hypermarket) Note : USD 1 = Rp 9,000

  47. Characteristics of Food & Beverages Business in Indonesia Competitive Environment • 1,159,983 food & beverages industries consist of : - 6,316 big / medium industries - 66,178 small industries - 1,087,489 home industries • 10,226,595 units of wholesaler/retailer • Multinational companies have entered food & beverages industry, modern retail, fast food, hotel, restaurant and plantation. • Imported raw material is still relatively high (e.g. flour, milk, soybean, meat)

  48. Output of Food Industries in Indonesia 2003 - 2008 ( in million US$) Source : Statistic of Indonesia 2009, Central Bureau of Statistics ( *) temporary data

  49. EXPORT & IMPORT OF PROCESSED FOODS (2003 – 2009*) (in million US$) Sumber : Central Bureau of Statistics 2009 (*) Jan – Sept’ 2009 (**) Jan - Nov’ 2009

More Related